Waters Corporation filings document operating results, proxy governance, capital-structure changes, material agreements, and corporate events for a NYSE-listed life sciences and diagnostics company. Recent 8-K reports include quarterly and annual results, exhibits furnished with earnings releases, and disclosure tied to the completed combination with BD’s Biosciences and Diagnostic Solutions business.
The company’s SEC record also covers senior unsecured notes issued by Augusta SpinCo Corporation and guaranteed by Waters and certain subsidiaries, pro forma and combined financial information for the acquired business, and definitive proxy materials addressing board oversight, shareholder voting matters, executive compensation, and governance practices.
Waters Corporation filed a Form 8-K to provide detailed historical and pro forma financial information for Becton, Dickinson’s former Biosciences and Diagnostic Solutions business acquired on February 9, 2026. The filing includes unaudited condensed combined financial statements, multi-year MD&A, and pro forma combined results for Waters and the acquired business.
For the three months ended December 31, 2025, the BDS Business generated revenues of $766 million, down from $834 million a year earlier, with net income of $49 million versus $78 million. Operating income fell to $35 million from $94 million, and gross margin declined as higher tariffs and labor costs more than offset productivity gains.
Segment data show Biosciences quarterly revenue of $327 million and Diagnostic Solutions revenue of $439 million, both lower than the prior year. For BD’s fiscal year 2025, the BDS Business reported worldwide revenues of $3,296 million, slightly below 2024, but maintained solid profitability with segment operating margins in the mid-teens to mid-30% range.
Waters Corporation director Richard H. Fearon bought 1,000 shares of common stock in an open-market transaction on March 6, 2026. The shares were purchased at a weighted average price of $306.34 per share, with individual trade prices ranging from $305.84 to $306.49. Following this purchase, he directly holds 3,302 Waters shares.
Waters Corporation President and CEO Udit Batra reported an automatic share disposition related to tax withholding. On this Form 4, 3,417 shares of common stock were withheld by the company at a price of $307.23 per share to cover tax obligations tied to vesting performance stock units.
These shares were not sold in an open-market transaction but were retained by the issuer to satisfy withholding requirements. After this tax-withholding disposition, Batra directly owned 33,140 shares of Waters common stock.
Waters Corp senior vice president and chief financial officer Amol Chaubal reported an insider transaction related to equity compensation. On this Form 4, 709 shares of common stock were withheld by the company on March 2, 2026 to satisfy tax obligations tied to the vesting of previously reported performance stock units, at a price of $307.23 per share. This was a tax-withholding disposition rather than an open-market sale. After this withholding, Chaubal directly holds 7,796.393 shares of Waters common stock.
Waters Corporation senior vice president Jianqing Bennett reported a tax-related share disposition. On this Form 4, 410 shares of common stock were withheld by the company at a price of $307.23 per share to satisfy tax withholding obligations tied to vesting of previously reported performance stock units. After this withholding, Bennett directly owns 6,834 shares of Waters common stock.
Carpio Robert L III reported acquisition or exercise transactions in this Form 4 filing.
Waters Corp senior vice president Robert L. Carpio III received new equity awards, not open-market purchases or sales. He was granted 4,884 stock options and 997 restricted stock units as of February 25, 2026. The options and RSUs both vest in four equal annual installments starting on February 25, 2027, contingent on his continued service. Following the RSU grant, his directly held common stock position is 3,615 shares.
Waters Corporation SVP Jianqing Bennett reported equity awards that increase his direct ownership. He received stock options for 4,826 shares at an exercise price of $0.0000 per share and a grant of 986 shares of common stock, both described as grant or award acquisitions.
The common stock grant represents restricted stock units that convert into one share of common stock each upon vesting and settlement. Both the RSUs and the stock options will vest in four equal annual installments, with the first installment scheduled to vest on February 25, 2027, contingent on his continued service with the company.
Waters Corporation SVP & Chief Financial Officer Amol Chaubal received new equity awards. He was granted a stock option covering 7,125 shares and an award of 1,455 shares of common stock as a grant or other acquisition at no cash cost per share.
The 1,455-share grant represents restricted stock units that vest in four equal annual installments starting on February 25, 2027, and convert into common stock on a one-to-one basis at settlement. The 7,125-share stock option also vests in four equal annual installments beginning on February 25, 2027, contingent on his continued service.
Waters Corporation President and CEO Udit Batra reported equity awards that increase his direct holdings through compensation grants, not open-market trades. He received a stock option covering 25,283 shares at a grant price of $0.00 and a grant of 5,165 shares of common stock.
The 5,165-share grant represents restricted stock units that convert one-for-one into common stock and vest in four equal annual installments starting on February 25, 2027, subject to continued service. The 25,283-share stock option also vests in four equal annual installments beginning on February 25, 2027, and becomes exercisable on the same schedule.
Waters Corporation director Mark Vergnano reported equity awards rather than open-market trades. On February 25, 2026, he received a grant of stock options for 57 shares at an exercise price of $0.00 per share and an award of 23 shares of common stock, both as acquisitions.
The 23 common shares are restricted stock that remain subject to restrictions until February 9, 2027, when 100% of these restrictions lapse. All 57 shares underlying the stock option will vest and become exercisable on February 9, 2027. After these awards, he directly owns 4,540 shares of Waters common stock.